Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer

Pathology International

Volumn 62, Issue 2, 2012, Pages 112-119

  Wakamatsu, Yuta ^a   Sakamoto, Naoya ^a   Oo, Htoo Zarni ^a   Naito, Yutaka ^a   Uraoka, Naohiro ^a   Anami, Katsuhiro ^a   Sentani, Kazuhiro ^a   Oue, Naohide ^a   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cancer stem cell; Gastric cancer; Metastasis; Stem cell marker

Indexed keywords

CD133 ANTIGEN; HERMES ANTIGEN; PROTEIN ALDEHYDE DEHYDROGENASE 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER STEM CELL; CANCER SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIMARY TUMOR; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL RATE; UNIVARIATE ANALYSIS;

AGED; ANTIGENS, CD; ANTIGENS, CD44; FEMALE; GLYCOPROTEINS; HUMANS; ISOENZYMES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; PEPTIDES; PROGNOSIS; RETINAL DEHYDROGENASE; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84855948607     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02760.x     Document Type: Article

References (38)

1. Ohgaki H, Matsukura N. Stomach cancer. In: Stewart BW, Kleihues P, eds. World Cancer Report. Lyon: IARC Press, 2003; 197.
2. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11.
3. Clark MF, Fuller M. Stem cells and cancer: Two faces of eve. Cell 2006; 124: 1111-15.
4. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8: 755-68.
5. Singh SK, Hawkins C, Clarke ID etal. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
6. Ricci-Vitiani L, Lombardi DG, Pilozzi E etal. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-5.
7. Singh SK, Clarke ID, Terasaki M etal. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-8.
8. Ishigami S, Ueno S, Arigami T etal. Prognostic impact of CD133 expression in gastric carcinoma. Anticancer Res 2010; 30: 2453-7.
9. Zhao P, Li Y, Lu Y. Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer 2010; 10: 218-23.
10. Nagano O, Murakami D, Hartmann D etal. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 2004; 165: 893-902.
11. Vigetti D, Viola M, Karousou E etal. Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging. J Biol Chem 2008; 283: 4448-58.
12. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-13.
13. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-8.
14. Yasui W, Kudo Y, Naka K etal. Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: Relation to the proliferation and progression. Int J Oncol 1998; 12: 1253-8.
15. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-51.
16. Li C, Heidt DG, Dalerba P etal. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-7.
17. Dalerba P, Dylla SJ, Park IK etal. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 2007; 104: 10158-63.
18. Takaishi S, Okumura T, Tu S etal. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009; 27: 1006-20.
19. Ginestier C, Hur MH, Charafe-Jauffret E etal. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-67.
20. Huang EH, Hynes MJ, Zhang T etal. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009; 69: 3382-9.
21. Moreb J, Schweder M, Suresh A, Zucali JR. Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide. Cancer Gene Ther 1996; 3: 24-30.
22. Liang D, Shi Y. Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma. Med Oncol (in press).
23. Jiang F, Qiu Q, Khanna A etal. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009; 7: 330-8.
24. Oue N, Mitani Y, Aung PP etal. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 2005; 207: 185-98.
25. Kojima M, Ishii G, Atsumi N etal. Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study. Cancer Sci 2008; 99: 1578-83.
26. Shimada Y, Ishii G, Nagai K etal. Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung. Cancer Sci 2009; 100: 2054-9.
27. Jiang F, Qiu Q, Khanna A etal. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009; 7: 330-8.
28. Harn HJ, Ho LI, Chang JY etal. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects. Cancer 1995; 75: 1065-71.
29. Du L, Wang H, He L etal. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 2008; 14: 6751-60.
30. Clevers H. The cancer stem cell: Premises, promises and challenges. Nat Med 2011; 17: 313-9.
31. Mills JC, Shivdasani RA. Gastric epithelial stem cells. Gastroenterology 2011; 140: 412-24.
32. Lee CJ, Li C, Simeone DM. Human pancreatic cancer stem cells: Implications for how we treat pancreatic cancer. Transl Oncol 2008; 1: 14-8.
33. Pantel K, Alix-Panabières C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009; 6: 339-51.
34. Charafe-Jauffret E, Ginestier C, Iovino F etal. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 2010; 16: 45-55.
35. Ponta H, Sherman L, Herrlich A. CD44: From adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003; 4: 33-45.
36. Ishimoto T, Oshima H, Oshima M etal. CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis. Cancer Sci 2010; 101: 673-8.
37. Ehata S, Johansson E, Katayama R etal. Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells. Oncogene 2011; 30: 1693-705.
38. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 2005; 65: 6207-19.